316 related articles for article (PubMed ID: 20206154)
21. Reactivation of human brain homogenate cholinesterases inhibited by Tabun using newly developed oximes K117 and K127.
Kuca K; Cabal J; Jung YS; Musilek K; Soukup O; Jun D; Pohanka M; Musilova L; Karasová J; Novotný L; Hrabinova M
Basic Clin Pharmacol Toxicol; 2009 Sep; 105(3):207-10. PubMed ID: 19473310
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
[TBL] [Abstract][Full Text] [Related]
23. Reactivation of organophosphate-inhibited serum butyrylcholinesterase by novel substituted phenoxyalkyl pyridinium oximes and traditional oximes.
Nichols RH; Chambers JE
Toxicology; 2021 Mar; 452():152719. PubMed ID: 33592259
[TBL] [Abstract][Full Text] [Related]
24. Effective bisquaternary reactivators of tabun-inhibited AChE.
Kuca K; Cabal J; Musilek K; Jun D; Bajgar J
J Appl Toxicol; 2005; 25(6):491-5. PubMed ID: 16092078
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, Biological Evaluation, and Docking Studies of Novel Bisquaternary Aldoxime Reactivators on Acetylcholinesterase and Butyrylcholinesterase Inhibited by Paraoxon.
Kuca K; Jun D; Junova L; Musilek K; Hrabinova M; da Silva JAV; Ramalho TC; Valko M; Wu Q; Nepovimova E; França TCC
Molecules; 2018 May; 23(5):. PubMed ID: 29735900
[TBL] [Abstract][Full Text] [Related]
26. Development of new acetylcholinesterase reactivators: molecular modeling versus in vitro data.
Ramalho TC; Tanos CC; Rennó MN; Guimarães AP; da Cunha EF; Kuca K
Chem Biol Interact; 2010 Sep; 187(1-3):436-40. PubMed ID: 20685354
[TBL] [Abstract][Full Text] [Related]
27. Development of new acetylcholinesterase reactivators: molecular modeling versus in vitro data.
Ramalho TC; França TC; Rennó MN; Guimarães AP; da Cunha EF; Kuca K
Chem Biol Interact; 2010 Apr; 185(1):73-7. PubMed ID: 20188081
[TBL] [Abstract][Full Text] [Related]
28. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
Grosfeld H; Barak D; Ordentlich A; Velan B; Shafferman A
Mol Pharmacol; 1996 Sep; 50(3):639-49. PubMed ID: 8794905
[TBL] [Abstract][Full Text] [Related]
29. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
Kuca K; Cabal J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
[TBL] [Abstract][Full Text] [Related]
30. Reactivation potency of two novel oximes (K456 and K733) against paraoxon-inhibited acetyl and butyrylcholinesterase: In silico and in vitro models.
Iqbal A; Malik S; Nurulain SM; Musilek K; Kuca K; Kalasz H; Fatmi MQ
Chem Biol Interact; 2019 Sep; 310():108735. PubMed ID: 31276662
[TBL] [Abstract][Full Text] [Related]
31. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties.
Bhattacharjee AK; Kuca K; Musilek K; Gordon RK
Chem Res Toxicol; 2010 Jan; 23(1):26-36. PubMed ID: 20028185
[TBL] [Abstract][Full Text] [Related]
32. Aging mechanism of butyrylcholinesterase inhibited by an N-methyl analogue of tabun: implications of the trigonal-bipyramidal transition state rearrangement for the phosphylation or reactivation of cholinesterases.
Nachon F; Carletti E; Worek F; Masson P
Chem Biol Interact; 2010 Sep; 187(1-3):44-8. PubMed ID: 20381476
[TBL] [Abstract][Full Text] [Related]
33. Investigation of the reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase.
Winter M; Wille T; Musilek K; Kuca K; Thiermann H; Worek F
Toxicol Lett; 2016 Feb; 244():136-142. PubMed ID: 26210933
[TBL] [Abstract][Full Text] [Related]
34. Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase.
Kovarik Z; Maček Hrvat N; Kalisiak J; Katalinić M; Sit RK; Zorbaz T; Radić Z; Fokin VV; Sharpless KB; Taylor P
Toxicol Appl Pharmacol; 2019 Jun; 372():40-46. PubMed ID: 30978400
[TBL] [Abstract][Full Text] [Related]
35. Effect of five acetylcholinesterase reactivators on tabun-intoxicated rats: induction of oxidative stress versus reactivation efficacy.
Pohanka M; Karasova JZ; Musilek K; Kuca K; Kassa J
J Appl Toxicol; 2009 Aug; 29(6):483-8. PubMed ID: 19338015
[TBL] [Abstract][Full Text] [Related]
36. Mechanistic studies of new oximes reactivators of human butyryl cholinesterase inhibited by cyclosarin and sarin.
de Lima WE; Francisco A; da Cunha EF; Radic Z; Taylor P; França TC; Ramalho TC
J Biomol Struct Dyn; 2017 May; 35(6):1272-1282. PubMed ID: 27125569
[TBL] [Abstract][Full Text] [Related]
37. Bisquaternary oximes as reactivators of tabun-inhibited human brain cholinesterases: an in vitro study.
Kuca K; Jun D; Cabal J; Musilova L
Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):25-8. PubMed ID: 17577312
[TBL] [Abstract][Full Text] [Related]
38. Interactions of butane, but-2-ene or xylene-like linked bispyridinium para-aldoximes with native and tabun-inhibited human cholinesterases.
Calić M; Bosak A; Kuca K; Kovarik Z
Chem Biol Interact; 2008 Sep; 175(1-3):305-8. PubMed ID: 18501885
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
40. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
